Webinar: Life after Treatment and Managing Late Effects

Lymphoma Australia invites you to our next free educational webinar tailored to patients, families, and carers of those affected by lymphoma.

Join us as we hear from Clinical Nurse Consultants’ Tracey Dryden and Natalie Goroncy from The Peter MacCallum Cancer Centre, who will explore life after treatment for lymphoma – including the transition from active treatment into the survivorship phase, navigating what long term follow up is involved, and how to manage the late effects of treatment – followed by an interactive Q and A session.

Event Details

Date: Thursday 11th June 2026
Time: 4:00pm to 5:00pm (NSW/VIC/ACT/TAS/QLD)
          3:30pm to 4:30pm (SA/NT)
          2:00pm to 3:00pm (WA)
Location: Online via Zoom – Link sent on registration
Cost: Free – Registration Required

About our Guest Presenters

Natalie Goroncy

Natalie Goroncy is the Late Effects Clinical Nurse Consultant at Peter MacCallum Cancer Centre and has been in this role for over 20 years. Natalie has years of experience in Haematology Nursing in both Adults and Paediatrics, in particular the Long Term Follow up of these patients. Natalie still enjoys coming to work everyday and helping patients to achieve their goals and learn to navigate life again after cancer treatment.

Tracey Dryden

Tracey Dryden is Haematology Clinical Nurse Consultant for Aggressive Lymphoma at Peter MacCallum Cancer Centre.

For more information or assistance with registering, please email nurse@lymphoma.org.au or call the Nurse Support Line on 1800 953 081.

There is limited availability for this event, so secure your spot quickly.
This event has already taken place.
Details
Date: Thursday 11th of June 2026
Time: 4:00pm AEST - 5:00pm AEST

Support and information

Contact Lymphoma Australia Today!

Please note:
Lymphoma Australia staff are only able to reply to emails sent in English language.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.